請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/15863完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李心予(Hsinyu Lee) | |
| dc.contributor.author | Yi-Long Huang | en |
| dc.contributor.author | 黃宜隆 | zh_TW |
| dc.date.accessioned | 2021-06-07T17:53:58Z | - |
| dc.date.copyright | 2012-08-22 | |
| dc.date.issued | 2012 | |
| dc.date.submitted | 2012-08-17 | |
| dc.identifier.citation | Selzer, A., Heart-Disease - a Textbook of Cardiovascular Medicine, 2nd Edition - Braunwald,E. New England Journal of Medicine, 1984. 310(20): p. 1337-1337.
2. Miao, D.M., et al., Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension. J Clin Hypertens (Greenwich), 2011. 13(10): p. 710-5. 3. Frenk, J., Disease control priorities in developing countries. Salud Publica De Mexico, 2006. 48(6): p. 522-525. 4. Guilbert, J.J., The search for HR continues: WHO's General Programme of Work 2002-2005 and the World Health Report 2001 on mental health. Educ Health (Abingdon), 2001. 14(3): p. 452-3. 5. Shibuya, K., et al., Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer, 2002. 2: p. 37. 6. Ross, R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993. 362(6423): p. 801-9. 7. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002. 324(7329): p. 71-86. 8. Baigent, C., et al., Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005. 366(9493): p. 1267-78. 9. Frohlich, E.D., Preventive cardiology: more than just lipid lowering. Prev Cardiol, 2001. 4(3): p. 101-102. 10. Ohki, S., et al., [Coronary artery bypass grafting in octogenarian]. Kyobu Geka, 2002. 55(10): p. 829-33; discussion 833-6. 11. Stephen, M., et al., Autogenous Veins and Velour Dacron in Femoropopliteal Arterial Bypass. Surgery, 1977. 81(3): p. 314-318. 12. Tissue engineering of vascular prosthetic grafts. Nat Med, 1999. 5(10): p. 1118. 13. Daniel, J., K. Abe, and P.S. McFetridge, Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. Asaio Journal, 2005. 51(3): p. 252-261. 14. Anders, A., H. Zuhlke, and R. Haring, Implantation of Formalin-Preserved Umbilical Veins as Dialysis Shunts - New Method of Allogenic Blood-Vessel Graft. Thoraxchirurgie Vaskulare Chirurgie, 1977. 25(6): p. 415-421. 15. Wellington, J.L., Umbilical vein grafts for vascular access in patients on long-term dialysis. Can J Surg, 1981. 24(6): p. 608-9. 16. Dardik, H. and Dardik, II, Successful arterial substitution with modified human umbilical vein. Ann Surg, 1976. 183(3): p. 252-8. 17. Daniel, J., K. Abe, and P.S. McFetridge, Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J, 2005. 51(3): p. 252-61. 18. Feletou, M., in The Endothelium: Part 1: Multiple Functions of the Endothelial Cells-Focus on Endothelium-Derived Vasoactive Mediators2011: San Rafael (CA). 19. Azuma, H., M. Ishikawa, and S. Sekizaki, Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol, 1986. 88(2): p. 411-5. 20. Aird, W.C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Research, 2007. 100(2): p. 158-73. 21. Verhamme, P. and M.F. Hoylaerts, The pivotal role of the endothelium in haemostasis and thrombosis. Acta Clinica Belgica, 2006. 61(5): p. 213-9. 22. Asahara, T., et al., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 1999. 85(3): p. 221-8. 23. Asahara, T., et al., Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997. 275(5302): p. 964-7. 24. Griendling, K.K., D. Sorescu, and M. Ushio-Fukai, NAD(P)H oxidase: role in cardiovascular biology and disease. Circulation Research, 2000. 86(5): p. 494-501. 25. Hill, J.M., et al., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003. 348(7): p. 593-600. 26. Leor, J. and M. Marber, Endothelial progenitors: a new Tower of Babel? J Am Coll Cardiol, 2006. 48(8): p. 1588-90. 27. Werner, N., et al., Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 2005. 353(10): p. 999-1007. 28. Reyes, M., et al., Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest, 2002. 109(3): p. 337-46. 29. Lin, Y., et al., Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest, 2000. 105(1): p. 71-7. 30. Case, J., D.A. Ingram, and L.S. Haneline, Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal, 2008. 10(11): p. 1895-907. 31. Sales, K.M., et al., Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol, 2005. 23(9): p. 461-7. 32. Miyata, T., et al., A new method to give an antithrombogenicity to biological materials and its successful application to vascular grafts. Trans Am Soc Artif Intern Organs, 1983. 29: p. 363-8. 33. Murohara, T., et al., Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest, 2000. 105(11): p. 1527-36. 34. Spiegel, S. and S. Milstien, Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol, 2003. 4(5): p. 397-407. 35. An, S., E.J. Goetzl, and H. Lee, Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J Cell Biochem Suppl, 1998. 30-31: p. 147-57. 36. Yatomi, Y., et al., Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat, 2001. 64(1-4): p. 107-22. 37. Yatomi, Y., et al., Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem, 1997. 121(5): p. 969-73. 38. Wang, F., et al., Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor - Potential involvement in angiogenesis. Journal of Biological Chemistry, 1999. 274(50): p. 35343-35350. 39. Yatomi, Y., et al., Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood, 1995. 86(1): p. 193-202. 40. Lee, H., E.J. Goetzl, and S. An, Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol, 2000. 278(3): p. C612-8. 41. Lin, C.I., et al., Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochem Biophys Res Commun, 2007. 355(4): p. 895-901. 42. Lee, H., Enhancement of Human Endothelial Cell Adhesion to Type I Collagen by Lysophosphatidic Acid (LPA) and Sphingosine-1-Phosphate (S1P). Taiwania, 2004. 49: p. 13. 43. Schaner, P.J., et al., Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg, 2004. 40(1): p. 146-53. 44. Gui, L., et al., Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods, 2010. 16(2): p. 173-84. 45. Gui, L., et al., Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A, 2009. 15(9): p. 2665-76. 46. Huang, N., et al., In vitro investigation of blood compatibility of Ti with oxide layers of rutile structure. J Biomater Appl, 1994. 8(4): p. 404-12. 47. Quint, C., et al., Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A, 2011. 108(22): p. 9214-9. 48. Stroncek, J.D., et al., Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue Eng Part A, 2009. 15(11): p. 3473-86. 49. Hsu, S.H., et al., The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys, 2005. 27(3): p. 267-72. 50. Herring, M.B., Endothelial cell seeding. J Vasc Surg, 1991. 13(5): p. 731-2. 51. Alobaid, N., et al., Single stage cell seeding of small diameter prosthetic cardiovascular grafts. Clin Hemorheol Microcirc, 2005. 33(3): p. 209-26. 52. Baker, K.S., et al., Endothelialization of human collagen surfaces with human adult endothelial cells. Am J Surg, 1985. 150(2): p. 197-200. 53. Goissis, G., et al., Preparation and characterization of collagen-elastin matrices from blood vessels intended as small diameter vascular grafts. Artif Organs, 2000. 24(3): p. 217-23. 54. Dutoya, S., et al., Elastin-derived protein coating onto poly(ethylene terephthalate). Technical, microstructural and biological studies. Biomaterials, 2000. 21(15): p. 1521-9. 55. Stansby, G., et al., Endothelial seeding of compliant polyurethane vascular graft material. Br J Surg, 1994. 81(9): p. 1286-9. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/15863 | - |
| dc.description.abstract | 心血管疾病是由心臟及血管病變所引起，也是國內十大死因之一。目前治療方式主要為繞道移植手術。因此，移植材料的選擇是一個很重要的議題。其中廣泛被認知的人類臍靜脈由於是天然血管因而被認為適合用於移植。在本實驗中,我們利用SDS來清除臍靜脈上面原有的細胞群,並利用FBS進一步清除殘留的核酸以防止免疫反應的發生並藉由組織切片及DNA定量的方式來確認細胞清除的效果。繼而再將臍靜脈內皮細胞 (Human umbilical vein endothelial cells, HUVECs)及內皮前驅細胞 (Endothelial progenitor cells, EPCs)種回臍靜脈。除了讓細胞在靜止及動態的環境下貼附，我們另外在種細胞的實驗中加入鞘氨醇1-磷酸鹽 (Sphingosine1-phosphate, S1P)，S1P是一種水解磷酯脂，其會調節細胞的分化、遷移及貼附。由實驗結果顯示，無論是靜態或是動態的環境下，S1P會增強內皮細胞貼附於去細胞的臍靜脈。之後的凝血時間測試顯示了有種細胞的臍靜脈有較強的抗凝血能力。我們的實驗架構中顯示此實驗提供了不同的製作血管的方法並減少人工血管的製作所需的時間。 | zh_TW |
| dc.description.abstract | Cardiovascular disease (CVD), disorders of the heart and blood vessels, is the leading cause of mortality and morbidity. Arterial bypass graft is a primary therapy for the CVD patients. Therefore, choosing a proper material for arterial bypass grafting is a critical issue. Human umbilical vein (HUV) is a natural vessel and has been suggested as a suitable scaffold for vascular tissue engineering. In this study, we successfully de-cellularized HUV by using sodium dodecyl sulfate (SDS) and further incubated with medium contains 12% FBS to remove the residual nucleic acid. After the de-cellularization procedures, human umbilical vein endothelial cells (HUVECs) and endothelial progenitor cell (EPC) were then seeded back on de-cellularized HUV in the presence of 1uM sphingosine 1-phosphate (S1P) in static or rotational cultural conditions. S1P is a lysophospholipid (LPL) which binds to G protein-coupled receptors (GPCRs) and enhances endothelial cell proliferation, migration, and adhesion. Our results showed that S1P enhances endothelial attachment on de-cellularized HUV in static and rotational cultural conditions and reduces time required for preparation of vessel grafts. The finding potentially provides a novel strategy to develop vascular tissues. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-07T17:53:58Z (GMT). No. of bitstreams: 1 ntu-101-R99B41019-1.pdf: 1456042 bytes, checksum: 9cb1263de81426188fe6fd936c4b6a92 (MD5) Previous issue date: 2012 | en |
| dc.description.tableofcontents | 口試委員會審定書……………………………………………………………………i
誌謝…………………………………………………………………………………....ii 中文摘要……………………………………………………………………………...iii ABSTRACT…………………………………………………………………………..iv INTRODUCTION…………………………………………………………………….1 Cardiovascular disease (CVD)………………………………………………………...1 Coronary artery disease (CAD)…………...…………………………………………..1 Coronary artery bypass surgery………………………………………………………..2 Human umbilical cord…………………………………………………………………3 Endothelium…………………………………………………………………………...4 Endothelium and antithrombogenicity………………………………………………...5 Endothelial progenitor cells………..…………………………………………….……6 Sphingosine-1-phosphate……………………………………………………………...6 RATIONALE………………………………………………………………………….9 MATERIALS AND METHODS……………………………………………………..10 Preparation of the human umbilical vein…………………………………………….10 Dissection of the human umbilical vein……………………………………………...10 De-cellularization of human umbilical vein…………………………………….……10 Determination of cellularity………………………………………………………….11 DNA quantification…………………………………………………………………...11 Cell culture…………………………………………………………………………...12 Cell staining…………………………………………………………………………..13 Cell treatment and seeding…………………………………………………………...14 Cell counting……………………………………………………………….…………14 Coagulation test………………………………………………………………………15 Statistical analysis……………………………………………………………………15 RESULTS…………………………………………………………………………….17 Histology analysis after de-cellularization…………………………………………..17 DNA quantification after de-cellularization…………………………………….……17 S1P enhances cell adhesion on human umbilical vein……………………………….18 Blood Compatibility…………………………………………………………………..19 DISCUSSION……………..…………………………………………………………21 Reference……………………………………………………………………………..26 FIGURES…………………………………………………………………………….34 Figures 1……………………………………………………………………………...34 Figures 2……………………………………………………………………………...36 Figures3…….………………………………………………………………….……..38 Figures 4……………………………………………………………………………...40 Figures 5……………………………………………………………………………...42 Figures 6……………………………………………………………………………...44 Figures 7……………………………………………………………………………..46 Figures 8……………………………………………………………………………...48 Figures 9…………………………………………………………………………...…50 Figures 10…………………………………………………………………………….52 | |
| dc.language.iso | en | |
| dc.title | 鞘氨醇1-磷酸鹽對於建構人工血管影響之探討 | zh_TW |
| dc.title | Sphingosine 1-phosphate Potentiated Endothelial Cell Attachment on De-cellularized Human Umbilical Vein as a Scaffold for Vascular Tissue Engineering | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 100-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 陳思原(Shee-Uan Chen),陸振翮(Jenher Lu) | |
| dc.subject.keyword | 心血管疾病,繞道移植手術,人類臍靜脈,內皮前驅細胞,鞘氨醇1-磷酸鹽, | zh_TW |
| dc.subject.keyword | cardiovascular disease,arterial bypass graft,human umbilical vein,endothelial progenitor cell,sphingosine 1-phosphate, | en |
| dc.relation.page | 53 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2012-08-17 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 動物學研究所 | zh_TW |
| 顯示於系所單位： | 動物學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-101-1.pdf 目前未授權公開取用 | 1.42 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。